Page last updated: 2024-08-21

aminoimidazole carboxamide and Hypertension, Portal

aminoimidazole carboxamide has been researched along with Hypertension, Portal in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dong, Z; George, J; Hu, L; Lv, Y; Su, L; Wang, J; Wu, Y	1

Other Studies

1 other study(ies) available for aminoimidazole carboxamide and Hypertension, Portal

Article	Year
AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model. Journal of molecular medicine (Berlin, Germany), 2019, Volume: 97, Issue:3 Topics: Actins; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Bile Ducts; Disease Models, Animal; Endothelial Cells; Hepatic Stellate Cells; Hypertension, Portal; Ligation; Liver Cirrhosis; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Rats, Sprague-Dawley; Ribonucleotides; Signal Transduction; Transforming Growth Factor beta	2019

Article

Year

AMPK agonist AICAR ameliorates portal hypertension and liver cirrhosis via NO pathway in the BDL rat model.

Journal of molecular medicine (Berlin, Germany), 2019, Volume: 97, Issue:3

Topics: Actins; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Bile Ducts; Disease Models, Animal; Endothelial Cells; Hepatic Stellate Cells; Hypertension, Portal; Ligation; Liver Cirrhosis; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Rats, Sprague-Dawley; Ribonucleotides; Signal Transduction; Transforming Growth Factor beta

2019